RohrJDufresneJJ. (1985). Dihydroergotamine nasal spray for the treatment migraine attacks: A comparative, double-blind, cross-over study with placebo. Cephalalgia5, Suppl. 3, 142–3.
2.
BousserM.G.LoriaY. (1985). Efficacy of diyhdroergotamine nasal spray in the acute treatment of migraine attacks. Cephalalgia5, Suppl. 3, 554–5.
3.
KrauseK.H.BleicherMA. (1985). Dihydroergotamine nasal spray in the treatment of migraine attacks. Cephalalgia5, Suppl. 3, 138–9.
4.
MassiouH. (1987). Dihydroergotamine nasal spray in prevention and treatment of migraine attacks: Two controlled trials versus placebo. Cephalalgia7, Suppl. 6, 440–1.
5.
Acezat-MispelterF.SouchetTLe BigotJ.F.GuilmontBDubrayC. (1987). Evaluation of nasal tolerability of diyhdroergotamine via the nasal route. Cephalalgia, 7suppl 6, 442–3.
6.
AnderssonP.G. (1986). Dihydroergotamine nasal spray in the treatment of cluster headache attacks. Cephalalgia6, 51–4.
